GSC
ELV icon

Grey Street Capital’s Elevance Health ELV Stock Holding History

Grey Street Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$841K Buy
+1,622
New +$807K 0.11% 203

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Grey Street Capital's ELV Position: Q1 2024 in Review

Grey Street Capital opened a new position in Elevance Health (ELV) in Q1 2024: 1,622 shares worth $841K. The stake represents 0.11% of the portfolio and ranks #203 among its holdings.

1,669 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Grey Street Capital held 1,622 shares of Elevance Health worth $841K as of Q1 2024.
  • Elevance Health was a new Grey Street Capital position in Q1 2024.
  • Elevance Health made up 0.11% of Grey Street Capital's portfolio in Q1 2024, its #203 holding.
  • 1,669 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.